Article info
Original research
Tramadol prescribed at discharge is associated with lower odds of chronic opioid use after elective total joint arthroplasty
- Correspondence to Dr Stavros G Memtsoudis, Anesthesiology, Critical Care & Pain Management, Hospital for Special Surgery, New York, NY 10021, USA; memtsoudiss{at}hss.edu
Citation
Tramadol prescribed at discharge is associated with lower odds of chronic opioid use after elective total joint arthroplasty
Publication history
- Received January 11, 2022
- Accepted June 12, 2022
- First published June 27, 2022.
Online issue publication
October 18, 2023
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© American Society of Regional Anesthesia & Pain Medicine 2022. No commercial re-use. See rights and permissions. Published by BMJ.